Patent for heart disease treatment:
This article was originally published in Clinica
US firm CorMedica has received a US patent for its minimally invasive laser heart surgery technology. The patent covers the company's percutaneous transluminal endocardial revascularisation (PTER) technology which uses electromagnetic navigation and tracking technology. CR Bard has worldwide rights for PTER and recently sold its coronary catheter laboratory business, along with the CorMedica relationship, to Arterial Vascular Engineering (see Clinica No 816, p 1).
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.